BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31278357)

  • 1. A practical guide for mutational signature analysis in hematological malignancies.
    Maura F; Degasperi A; Nadeu F; Leongamornlert D; Davies H; Moore L; Royo R; Ziccheddu B; Puente XS; Avet-Loiseau H; Campbell PJ; Nik-Zainal S; Campo E; Munshi N; Bolli N
    Nat Commun; 2019 Jul; 10(1):2969. PubMed ID: 31278357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome Sequencing and Analysis Methods in Chronic Lymphocytic Leukemia.
    Quesada V; Araujo-Voces M; Pérez-Silva JG; Velasco G; López-Otín C
    Methods Mol Biol; 2019; 1881():319-325. PubMed ID: 30350214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational signature assignment heterogeneity is widespread and can be addressed by ensemble approaches.
    Wu AJ; Perera A; Kularatnarajah L; Korsakova A; Pitt JJ
    Brief Bioinform; 2023 Sep; 24(6):. PubMed ID: 37742051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A BRCA1/2 Mutational Signature and Survival in Ovarian High-Grade Serous Carcinoma.
    Dong F; Davineni PK; Howitt BE; Beck AH
    Cancer Epidemiol Biomarkers Prev; 2016 Nov; 25(11):1511-1516. PubMed ID: 27496093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benchmarking of Amplicon-Based Next-Generation Sequencing Panels Combined with Bioinformatics Solutions for Germline BRCA1 and BRCA2 Alteration Detection.
    Vendrell JA; Vilquin P; Larrieux M; Van Goethem C; Solassol J
    J Mol Diagn; 2018 Nov; 20(6):754-764. PubMed ID: 30055349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative genomic analysis identifies associations of molecular alterations to APOBEC and BRCA1/2 mutational signatures in breast cancer.
    Trevino V
    Mol Genet Genomic Med; 2019 Aug; 7(8):e810. PubMed ID: 31294536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational processes contributing to the development of multiple myeloma.
    Hoang PH; Cornish AJ; Dobbins SE; Kaiser M; Houlston RS
    Blood Cancer J; 2019 Aug; 9(8):60. PubMed ID: 31387987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Somatically Acquired
    Vidula N; Dubash T; Lawrence MS; Simoneau A; Niemierko A; Blouch E; Nagy B; Roh W; Chirn B; Reeves BA; Malvarosa G; Lennerz J; Isakoff SJ; Juric D; Micalizzi D; Wander S; Spring L; Moy B; Shannon K; Younger J; Lanman R; Toner M; Iafrate AJ; Getz G; Zou L; Ellisen LW; Maheswaran S; Haber DA; Bardia A
    Clin Cancer Res; 2020 Sep; 26(18):4852-4862. PubMed ID: 32571788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns.
    Sørensen SG; Shrikhande A; Poulsgaard GA; Christensen MH; Bertl J; Laursen BE; Hoffmann ER; Pedersen JS
    Elife; 2023 Mar; 12():. PubMed ID: 36883553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CaMuS: simultaneous fitting and de novo imputation of cancer mutational signature.
    Cartolano M; Abedpour N; Achter V; Yang TP; Ackermann S; Fischer M; Peifer M
    Sci Rep; 2020 Nov; 10(1):19316. PubMed ID: 33168834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational signatures: experimental design and analytical framework.
    Koh G; Zou X; Nik-Zainal S
    Genome Biol; 2020 Feb; 21(1):37. PubMed ID: 32059681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of Mutational Signature Analysis with 3D Chromatin Data Unveils Differential AID-Related Mutagenesis in Indolent Lymphomas.
    Sepulveda-Yanez JH; Alvarez-Saravia D; Fernandez-Goycoolea J; Aldridge J; van Bergen CAM; Posthuma W; Uribe-Paredes R; Veelken H; Navarrete MA
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single base substitution mutational signatures in pediatric acute myeloid leukemia based on whole genome sequencing.
    Gunnarsson R; Yang M; Olsson-Arvidsson L; Biloglav A; Behrendtz M; Castor A; Paulsson K; Johansson B
    Leukemia; 2021 May; 35(5):1485-1489. PubMed ID: 33864028
    [No Abstract]   [Full Text] [Related]  

  • 14. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.
    Malcikova J; Tausch E; Rossi D; Sutton LA; Soussi T; Zenz T; Kater AP; Niemann CU; Gonzalez D; Davi F; Gonzalez Diaz M; Moreno C; Gaidano G; Stamatopoulos K; Rosenquist R; Stilgenbauer S; Ghia P; Pospisilova S;
    Leukemia; 2018 May; 32(5):1070-1080. PubMed ID: 29467486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.
    Lionetti M; Fabris S; Cutrona G; Agnelli L; Ciardullo C; Matis S; Ciceri G; Colombo M; Maura F; Mosca L; Gentile M; Recchia AG; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Rossi D; Gaidano G; Morabito F; Ferrarini M; Neri A
    Br J Haematol; 2014 Jun; 165(5):629-39. PubMed ID: 24579978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-evaluating experimental validation in the Big Data Era: a conceptual argument.
    Jafari M; Guan Y; Wedge DC; Ansari-Pour N
    Genome Biol; 2021 Feb; 22(1):71. PubMed ID: 33627141
    [No Abstract]   [Full Text] [Related]  

  • 17. Multi-scale characterisation of homologous recombination deficiency in breast cancer.
    Jacobson DH; Pan S; Fisher J; Secrier M
    Genome Med; 2023 Nov; 15(1):90. PubMed ID: 37919776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
    Rigolin GM; Saccenti E; Bassi C; Lupini L; Quaglia FM; Cavallari M; Martinelli S; Formigaro L; Lista E; Bardi MA; Volta E; Tammiso E; Melandri A; Urso A; Cavazzini F; Negrini M; Cuneo A
    J Hematol Oncol; 2016 Sep; 9(1):88. PubMed ID: 27633522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trajectory and uniqueness of mutational signatures in yeast mutators.
    Loeillet S; Herzog M; Puddu F; Legoix P; Baulande S; Jackson SP; Nicolas AG
    Proc Natl Acad Sci U S A; 2020 Oct; 117(40):24947-24956. PubMed ID: 32968016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies.
    Rozenfeld-Granot G; Toren A; Amariglio N; Brok-Simoni F; Rechavi G
    Exp Hematol; 2001 Feb; 29(2):228-33. PubMed ID: 11166462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.